Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator
US9933436B2 · kind B2 · utility
0Cited by
3References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 7, 2012 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | Sep 7, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/20
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a method of evaluating cellulite using fibulin-3 and/or sarcoglycan gamma as an indicator in a harvested skin sample, and a method of evaluating a drug for improving, preventing or treating cellulite using fibulin-3 and/or sarcoglycan gamma as an indicator in cultured cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.